Dual Receptor Small Molecules for Glucose and Weight Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for calcitonin and amylin receptor-associated diseases, such as diabetes and obesity, lack effective modulators that can regulate blood glucose and induce weight loss.
Innovation Solution
Development of small molecule calcitonin and amylin receptor modulators, including pharmaceutical compositions and methods for administering these compounds to treat associated diseases or disorders, alongside additional therapies like antidiabetic agents and weight loss agents.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments for calcitonin and amylin receptor-associated diseases are used, then existing therapeutic options are available, but effective regulation of blood glucose and induction of weight loss cannot be achieved
Solution Approach 1:
The patent develops small molecule compounds that can modulate both calcitonin receptors and amylin receptors simultaneously, creating a multi-functional therapeutic agent that addresses multiple metabolic disorders (diabetes, obesity, weight management) with a single compound, thereby achieving both reliable therapeutic effectiveness and broad disease coverage
2Reliability
If small molecule calcitonin and amylin receptor modulators are developed, then effective blood glucose regulation and weight loss induction can be achieved, but the complexity of drug development increases
Solution Approach 1:
The patent combines calcitonin receptor modulating activity and amylin receptor modulating activity into a single small molecule compound structure, eliminating the need for multiple separate drugs and simplifying the overall treatment regimen while achieving effective metabolic control through dual receptor modulation
Data Source
AI summary
The present disclosure provides compounds for modulating calcitonin receptor and/or amylin receptor activity, as well as pharmaceutical compositions comprising the compounds disclosed herein. Also provided are methods for treating a calcitonin receptor and/or amylin receptor associated disease or disorder.